10 likes | 49 Views
To order this 250 page report, which features 140 figures and 170 tables, please visit https://www.rootsanalysis.com/reports/view_document/endocannabinoid-therapeutics/316.html<br><br>Key Inclusions<br>uf0a7tA detailed assessment of the current market landscape of endocannabinoid system targeted therapeutics, providing information on phase of development (clinical, preclinical, and discovery stage) of lead candidates, target therapeutic area (s), route of administration (oral, topical, sublingual, oromucosal, inhalation and others), dosing frequency (once daily, twice daily, thrice daily and others) and target receptor (CB1, CB2, TRPV-1 and others). Additionally, the chapter includes information on drug developer(s), including information on year of establishment, company size, and location of headquarters.<br>
E N D